Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction

Lancet

Volumn 357, Issue 9265, 2001, Pages 1325-1328

  Enne, Virve I ^a   Livermore, David M ^b   Stephens, Peter ^c   Hall, Lucinda M C ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULFONAMIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC LINKAGE; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0035962337     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04519-0     Document Type: Article

References (14)

1. Anon. Co-trimoxazole use restricted. Drug Ther Bull 1995; 33: 92-93.
2. Liu P.Y.F., Gur D., Hall L.M.C., Livermore D.M. Survey of the prevalence of β-lactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother. 30:1992;429-447.
3. Lawrenson R.A., Coles G., Walton K., Farmer R.D.T. Characteristics of practices contributing the MediPlus database and the implications for its use in epidemiological research. J Inform Primary Care 1998; May 14-18.
4. British Society for Antimicrobial Chemotherapy. BSAC standardized disk sensitivity testing method. Birmingham: BSAC, 1998: 19.
5. NCCLS. Performance standards for antimicrobial susceptibility testing; ninth informational supplement. Villanova, Pa: NCCLS, 1999; 19: 32-35.
6. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 2nd edn :1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
7. Livermore D.M., Williams J.D. β-lactams: mode of action and mechanisms of antibacterial resistance. Lorian V. Antibiotics in laboratory medicine. 4th edn :1996;561 Williams & Wilkins, Baltimore.
8. Radstrom P., Swedberg G., Skold O. Genetic analyses of sulfonamide resistance and its dissemination in Gram-negative bacteria illustrate new aspects of R plasmid evolution. Antimicrob Agents Chemother. 35:1991;1840-1848.
9. Hall R.M. Mobile gene cassettes and integrons: moving antibiotic resistance genes in Gram-negative bacteria. CIBA Found Symp. 207:1997;192-202.
10. Bouma J.E., Lenski R.E. Evolution of a bacteria-plasmid association. Nature. 335:1988;351-352.
11. Schrag S.J., Perrot V., Levin B.R. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Roy Soc Lond B Biol Sci. 264:1997;1287-1291.
12. Veterinary Medicines Directorate. Sales on antimicrobial products used as veterinary medicines or growth promoters in the UK from 1993 to 1998. www.open.gov.uk/vdm/rdmhome.html (accessed on April 28, 2001).
13. Seppala H., Klaukka T., Vuopio-Varkila J., et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med. 337:1997;441-446.
14. Huovinen P., Seppala H., Kataja J., Klaukka T., and the Finnish Study Group for Antimicrobial Resistance. The relationship between erythromycin consumption and resistance in Finland. CIBA Found Symp 1997; 207: 36-41.